{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:31:02Z","timestamp":1781969462518,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.radcr.2024.08.032","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:23:44Z","timestamp":1725665024000},"page":"5589-5594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Extensive brainstem lesions in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A case report"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1152-7487","authenticated-orcid":false,"given":"Yasuyuki","family":"Kojita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonoka","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Satou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-952X","authenticated-orcid":false,"given":"Kazunari","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radcr.2024.08.032_bib0001","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and mri features, Diagnosis, and Management","volume":"13","author":"Sechi","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.radcr.2024.08.032_bib0003","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrneurol.2011.45","article-title":"White matter disease: roles of antiMOG antibodies in demyelinating diseases","volume":"7","author":"Olsson","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0004","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00415-020-10026-y","article-title":"Treatment of MOG antibody associated disorders: results of an international survey","volume":"267","author":"Whittam","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0006","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.radcr.2024.08.032_bib0007","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.radcr.2024.08.032_bib0008","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458514566666","article-title":"Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort","volume":"21","author":"Ketelslegers","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.radcr.2024.08.032_bib0009","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jnnp-2020-325121","article-title":"Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS","volume":"92","author":"Banks","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.radcr.2024.08.032_bib0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577875","article-title":"MOG autoimmunity mimicking CLIPPERS syndrome: case report and literature review","volume":"367","author":"Ferilli","year":"2022","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0012","article-title":"A case of MOGAD optic neuritis initially mis-classified as CLIPPERS","volume":"3","author":"Zerpa","year":"2023","journal-title":"Neuroimmunol Rep"},{"key":"10.1016\/j.radcr.2024.08.032_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102874","article-title":"Peppering the pons\u201d: CLIPPERS or myelin oligodendrocyte glycoprotein associated disease?","volume":"51","author":"Obeidat","year":"2021","journal-title":"Multiple Sclerosis Related Disord"},{"key":"10.1016\/j.radcr.2024.08.032_bib0014","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/brain\/awq164","article-title":"Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)","volume":"133","author":"Pittock","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.radcr.2024.08.032_bib0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/jnnp-2018-318957","article-title":"CLIPPERS and its mimics: evaluation of new criteria for the diagnosis of CLIPPERS","volume":"90","author":"Taieb","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.radcr.2024.08.032_bib0016","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/brain\/awx200","article-title":"Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)","volume":"140","author":"Tobin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.radcr.2024.08.032_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211062821","article-title":"Brain biopsy in patients with CLIPPERS syndrome: why and when? A case report and literature review","volume":"15","author":"Galazky","year":"2022","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.radcr.2024.08.032_bib0018","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cei.12204","article-title":"CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders","volume":"175","author":"Dudesek","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0019","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3174\/ajnr.A4867","article-title":"Diffusion-weighted imaging for predicting and monitoring primary central nervous system lymphoma treatment response","volume":"37","author":"Huang","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0020","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00415-006-0165-4","article-title":"Unusual MRI findings in primary central nervous system lymphoma presenting diffuse linear enhancements located in the perivascular space","volume":"253","author":"Ichikawa","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191341","article-title":"Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach","volume":"13","author":"Neska-Matuszewska","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.radcr.2024.08.032_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00259-022-05950-2","article-title":"Correction to: [18F]FDG brain PET findings in CLIPPERS at diagnosis and therapeutic follow-up","volume":"50","author":"Horowitz","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radcr.2024.08.032_bib0023","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11060-017-2686-3","article-title":"18F-FDG PET\/CT in primary brain lymphoma","volume":"136","author":"Albano","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0024","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.radcr.2024.08.032_bib0025","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","article-title":"Neurological update: MOG antibody disease","volume":"266","author":"Wynford-Thomas","year":"2019","journal-title":"J Neurol"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043324008100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043324008100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:29:11Z","timestamp":1736436551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043324008100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1930043324008100"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2024.08.032","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extensive brainstem lesions in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A case report","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2024.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}